Anpario (LON:ANP) Stock Price Down 11.9% – Should You Sell?

Anpario plc (LON:ANPGet Free Report)’s share price was down 11.9% during trading on Wednesday . The stock traded as low as GBX 467 and last traded at GBX 480. Approximately 221,767 shares changed hands during trading, an increase of 387% from the average daily volume of 45,508 shares. The stock had previously closed at GBX 545.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on ANP shares. Shore Capital Group reaffirmed a “house stock” rating on shares of Anpario in a research note on Monday, August 17th. Canaccord Genuity Group reiterated a “buy” rating and set a GBX 570 price objective on shares of Anpario in a research note on Friday, June 26th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of GBX 570.

Check Out Our Latest Analysis on ANP

Anpario Stock Performance

The company’s 50-day moving average price is GBX 532.43 and its two-hundred day moving average price is GBX 517.42. The company has a market cap of £78.17 million, a P/E ratio of 12.65 and a beta of 1.08. The company has a current ratio of 4.50, a quick ratio of 5.16 and a debt-to-equity ratio of 0.60.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Further Reading

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.